• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsSyncom Formulations (India)
    Picture of Syncom Formulations (India) logo

    SYNCOMF — Syncom Formulations (India) Share News

    IN₹14.270.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapHigh Flyer
    • Market Cap
      IN₹13.41bn
    • Enterprise Value
      IN₹12.26bn
    • Revenue
      IN₹4.89bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SYNCOMF Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SYNCOMF Dividends
    • Brief: Syncom Formulations (India) Says Rahul Vijay Bankda Appointed As CFO Effective August 9

      08/08/2025 12:57
    • Brief: Syncom Formulations (India) To Commence Manufacturing, Marketing Of Generic Products

      30/08/2024 11:36
    • Brief: Syncom Formulations (India) Re-Appoints Kedarmal Shankarlal Bankda As Chairman

      12/08/2024 12:34
    • Brief: Syncom Formulations (India) Commences Commercial Production In Pithampur Plant

      21/08/2023 14:54
    • Brief: Syncom Formulations (India) June-Quarter Consol Profit Rises

      14/08/2023 10:51

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.